IP Library › Patent Application 61052573
Patent Application Provisional
App. No. 61/052,573 · Confirmation No. 2922

PREDICTIVE UTILITY OF PROGESTERONE RECEPTOR (PR) AND MULTIGENE EXPRESSION IN IDENTIFYING BENEFIT FROM ADJUVANT DOXORUBICIN PLUS CYCLOPHOSPHAMIDE (AC) OR DOCETAXEL (AT) IN INTERGROUP TRIAL E2197

Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2008-05-20 APP.FILE.REC Filing Receipt 3 View
2008-05-12 TR.PROV Provisional Cover Sheet (SB16) 2 View
2008-05-12 SPEC Specification 1 View
2008-05-12 WFEE Fee Worksheet (SB06) 2 View
2008-05-12 N417 Electronic Filing System Acknowledgment Receipt 2 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
61/052,573
Filed
2008-05-12